bexarotene has been researched along with Sensitivity and Specificity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loewen, G; van de Merbel, NC; van Veen, JH; Wilkens, G | 1 |
| Benoit, B; Budgin, JB; Newton, SB; Richardson, SK; Rook, AH; Wysocka, M; Zaki, MH | 1 |
| Brown, PH; Green, JE; Hilsenbeck, SG; Kim, HT; Kuhn, JG; Lamph, WW; Mohsin, SK; Rodriquez, JL; Wu, K; Xu, XC | 1 |
3 other study(ies) available for bexarotene and Sensitivity and Specificity
| Article | Year |
|---|---|
Validated liquid chromatographic method for the determination of bexarotene in human plasma.
Topics: Bexarotene; Calibration; Chromatography, Liquid; Humans; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Tetrahydronaphthalenes | 2002 |
Biological effects of bexarotene in cutaneous T-cell lymphoma.
Topics: Apoptosis; Bexarotene; Case-Control Studies; Cytokines; Drug Synergism; Female; Flow Cytometry; Humans; Interferon-alpha; Interferon-gamma; Interleukin-4; Leukocytes, Mononuclear; Male; Reference Values; Risk Factors; Sensitivity and Specificity; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes; Tumor Cells, Cultured | 2005 |
Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Benzoates; Bexarotene; Biomarkers, Tumor; Breast Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Growth Inhibitors; Histones; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Sensitivity and Specificity; Tetrahydronaphthalenes; Time Factors; Transcription Factors; Treatment Outcome | 2002 |